QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing

by Ysios Capital

QIAGEN N.V. has announced it has entered into an agreement to acquire STAT-Dx, a privately-held company developing the next generation of multiplex diagnostics for one-step, fully integrated molecular...

Read more

Stat Diagnostica announces 25 Million Euros in Series C Financing led by Gilde Healthcare

by Caixa Capital Risc

Led by new investor Gilde Healthcare , the financing round also drew participation from existing investors , including Kurma Partners ; Ysios Capital ; Idinvest Partners ; Boehringer Ingelheim Venture...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

MyInvestor comercializa Actyus Growth Fi...

by Professional Newco

El fondo invertirá en una cartera de entre 20 y 30 compañías europe...

Photos Stream